Bristol-Myers Squibb (BMY) Faces Mixed Analyst Sentiment Despite Strong Momentum in Healthcare Industry

Bristol-Myers Squibb Company (NYSE:BMY) is included in our list of the best stocks to buy for financial stability. Bristol-Myers Squibb (BMY) Faces Mixed Analyst Sentiment Despite Strong Momentum in Healthcare Industry Bristol-Myers Squibb Company (NYSE:BMY) is facing mixed analyst sentiment, with roughly 60% of covering analysts maintaining mixed ratings on the stock. At the same time, the consensus price target of $63 implies 10% upside. The recent analyst update came from HSBC, in which analysts emph ...